ReShape Lifesciences up on patent for weight loss device
** ReShape Lifesciences Inc's RSLS.O shares up 7.4% at
$2.84
** Company received notice of allowance from U.S. patent and
trademark office for patent related to its non-surgical weight
loss device, Obalon Balloon System
** Including session gains, stock down ~57%
(Reporting by Khushi Mandowara in Bengaluru)
((Khushi.Mandowara@thomsonreuters.com))
Recent news on Vyome Holdings
See all newsBrief: Vyome - Appoints Jerry Leonard As CFO On August 27, 2026 - SEC Filing
Biopharma firm Vyome Holdings posts Q2 net loss
Vyome Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Vyome Holdings Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity